The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
May. 05, 2017
Applicant:
Exicure Operating Company, Chicago, IL (US);
Inventors:
Richard Kang, Wilmette, IL (US);
Scott Mix, Chicago, IL (US);
Ekambar Kandimalla, Hopkinton, MA (US);
Assignee:
Exicure Operating Company, Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 47/69 (2017.01); A61K 47/54 (2017.01); A61K 31/712 (2006.01); A61K 31/7125 (2006.01); A61K 31/713 (2006.01); A61K 9/06 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/712 (2013.01); A61K 31/713 (2013.01); A61K 31/7125 (2013.01); A61K 47/554 (2017.08); A61K 47/6911 (2017.08); A61K 9/06 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/341 (2013.01);
Abstract
Aspects of the invention relate to antisense oligonucleotides directed to the interleukin 17 receptor (IL-17R), and other targets. Spherical nucleic acid formulations or compositions of antisense oligonucleotides and related methods of treatment are also provided.